Home > Result Summaries: Compounds > ropinirole > Result Summary for 101468/032

Result Summary for 101468/032

Result Summary

Protocol ID:	101468/032
Clinical Study ID:	101468/032
Official Title:	Anti-Parkinson Efficacy of Ropinirole (SKF 101468) versus Placebo as Monotherapy in Parkinson's Disease
Phase:	Phase 2
Study Indications or Diseases:	Parkinson Disease
Generic Name:	ropinirole
Trade/Product Name:	requip;requip
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Rascol O. Anti Parkinson efficacy of ropinirole vs placebo as early therapy in Parkinson's disease. International Symposium on Parkinson's Disease, Rome, Italy, Mar 26-30, 1994. New Trends Clin Neuropharmacol 1994; 8: 279 Brooks DJ, Abbott RJ, Lees AJ et al. A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease. Clin Neuropharmacol 1998; 21: 101-107 Brooks DJ, Torjanski N, Burn DJ. Ropinirole in the symptomatic treatment of Parkinson's disease. J Neural Transm 1995; 45 (suppl): 231-238